发明名称 H2 antagonist-gastrointestinal motility agent combinations
摘要 This invention relates to pharmaceutical compositions for use in the prevention, treatment and relief of indigestion, sour stomach, heartburn, gastroesophageal reflux, dyspepsia, constipation, over-indulgence and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs thereof, and (ii) an amount effective in the relief of gastrointestinal or esophagus disorders and in the promotion of gastric emptying of a gastrointestinal motility agent such as cisapride, and optionally (iii) an amount effective in the relief of flatulence of simethicone or alpha-D-galactosidase.
申请公布号 AU7397194(A) 申请公布日期 1995.02.06
申请号 AU19940073971 申请日期 1994.07.05
申请人 MERCK & CO., INC.;MCNEIL-PPC, INC. 发明人 ROBERT T SIMS;WILLIAM SLIVKA
分类号 A61K38/46;A61K31/16;A61K31/215;A61K31/415;A61K31/425;A61K31/445;A61K31/80;A61K38/47 主分类号 A61K38/46
代理机构 代理人
主权项
地址